
BCRX vs DNA
$BCRX vs $DNA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BCRX vs DNA: the quick read
- ·BCRX is the larger company by market cap ($2.18B vs $875M).
- ·DNA has been more active on our scanner (366 vs 92 alerts in 30 days).
- ·DNA has the smaller float (62.0M vs 245.6M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·DNA draws far more of our scanner's attention, 366 unusual-volume alerts in 30 days against 92, so it is the more actively traded of the two by some distance.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BCRX and DNA on TheDesperateTrader.
- Is BCRX or DNA the better stock?
- "Better" depends on your goal, and these two are not alike. BCRX is the larger company by market cap ($2.18B vs $875M). DNA has been more active on our scanner (366 vs 92 alerts in 30 days). DNA has the smaller float (62.0M vs 245.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BCRX and DNA?
- The differences that matter: they are similar in size ($2.18B vs $875M); they trade at very different share prices ($8.55 vs $13.02); BCRX sits at 49% of its 52-week range against 60% for DNA; our scanner flagged BCRX 92 times in the last 30 days against 366 for DNA. Everything above is measured from the latest completed session and SEC filings.
- Which of BCRX and DNA is more active right now?
- Right now BCRX is at about 0.5x its normal volume and DNA is at about 1.8x, so DNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BCRX or DNA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore BCRX and DNA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.